Hong Kong Pharma Digital Technology Holdings Limited (HKPD)

HKPD Income Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023
Revenue	16.69	16.69	12.56
Revenue Growth (YoY)	-	32.91%	-
Cost of Revenue	13.13	13.13	9.82
Gross Profit	3.56	3.56	2.74
Selling, General & Admin	1.89	1.89	1.76
Other Operating Expenses	0.06	0.06	0.03
Operating Expenses	1.95	1.95	1.79
Operating Income	1.61	1.61	1.04
Interest Expense / Income	0.08	0.08	0.02
Pretax Income	1.53	1.53	1.02
Income Tax	0.2	0.2	0.02
Net Income	1.33	1.33	1
Net Income Growth	-	33.21%	-
Free Cash Flow	-0.48	-0.48	1.61
Gross Margin	21.32%	21.32%	21.81%
Operating Margin	9.64%	9.64%	8.31%
Profit Margin	7.97%	7.97%	7.95%
Free Cash Flow Margin	-2.89%	-2.89%	12.82%
Effective Tax Rate	12.86%	12.86%	2.21%
EBITDA	2.53	2.53	1.76
EBITDA Margin	15.18%	15.18%	14.00%
Depreciation & Amortization	0.93	0.93	0.71
EBIT	1.61	1.61	1.04
EBIT Margin	9.64%	9.64%	8.31%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).